Bacterial Antigen Ingredients TRIZ Cases

Inactivated mycoplasmal strains combined with adjuvants overcome antimicrobial resistance to reduce mortality and restore egg production.

Alcohol precipitation and gel filtration isolate Burkholderia capsular polysaccharides, reducing extraction time from 20 days to 7-9 days.

Low-dose purified native antigens reduce parasite burden while avoiding recombinant failure.

Sugar alcohols and amino acids stabilize live attenuated bovine viruses in liquid form, eliminating lyophilization costs.

Fluorescent cell substrates replace animal toxicity studies by measuring optical signal changes during toxin cleavage.

LMB64 bacterial extracts resolve high treatment costs by replacing monoclonal antibodies with self-sustaining probiotic therapy.

A rapid diagnostic test uses C-reactive protein binding to phosphorylcholine on pathogenic bacteria surfaces.

An elongate chamber with a traveling carrier agitates liquid samples to accelerate analyte binding.

Segmented Mfa1 and Gingipain antigens in the vaccine induce specific immunity that reduces disease severity while preserving beneficial oral microbes.

Replacing sodium hydroxide with carbonate ions prevents acidification and maintains polysaccharide molecular weight above 700 kDa.

Individual antigen adsorption onto aluminium phosphate adjuvants reduces reactogenicity while maintaining stability in a fully liquid combination vaccine.

Rv3879c peptides eliminate cross-reactivity with BCG and environmental mycobacteria, resolving specificity issues in TB diagnosis.

Recombinant paramyosin purification uses strand separation agents to isolate monomers and restore coiled coil dimers for vaccine antigens.

Klebsiella pneumoniae 2H7 strain induces Th1 cell proliferation in the intestine to activate host immunity.

Combining C. difficile and C. perfringens toxoids in one injection simplifies procedures while protecting against multiple pathogens.

Controlled acidification precipitates soluble proteins from Streptococcus pneumoniae lysate broth prior to purification.

A freeze-dried MTBVAC vaccine composition uses sucrose and sodium glutamate to stabilize the attenuated strain.

Genetically modified non-toxigenic Clostridium difficile spores deliver immunogenic proteins to induce protective antibodies.

Recombinant expression of specific antigens reduces manufacturing costs while maintaining protection against Mycoplasma hyorhinis infections.

A composite vaccine combines multiple pathogen epitopes into a single peptide sequence to stimulate broad immune responses.

Blocking the PD-1 ligand interaction pathway overcomes sub-optimal immune responses to boost protective IgG levels in pneumococcal vaccines.

Deleting P30 exposure sequences and adhesin genes reduces pathogenicity while maintaining secretion capability.

Multi-antigen alphavirus RNA replicon particles overcome Borrelia genetic diversity by inducing robust borreliacidal and opsonizing IgG antibody responses.

C-terminal truncation yields soluble, catalytically active botulinum toxin light chains for structure-function studies.

Parabacteroides goldsteinii reduces glomeruli sclerosis and inflammation, addressing chronic kidney disease limitations.

PspA Asn to Asp mutation prevents deamination at neutral pH, ensuring vaccine stability.

Chelating agents in the growth medium boost pyolysin yield, addressing low production levels for bovine metritis vaccines.

Replication-defective adenovirus vector overcomes pre-existing immunity by substituting E4 regions with Ad5 sequences.

Merging PD-1 and LAG-3 inhibitors overcomes resistance in tumors that fail single-agent therapy, improving survival rates.

Segmented nucleic acid sequences distinguish Tenacibaculum from Moritella, resolving diagnostic ambiguity in farmed fish.

Detecting SpeA-specific killer T follicular helper cells enables targeted immune modulation strategies.

A dry powder vaccine formulation adsorbs antigens to aluminum adjuvants for stable storage and needle-free delivery.

Spray drying transforms liquid vaccine emulsions into dry powder compositions that remain stable at ambient temperatures, eliminating cold chain requirements.

Attenuated Burkholderia pseudomallei outer membrane vesicles stimulate CD4 and CD8 T cell responses without diminishing humoral immunity.